Want to reduce the risk of obesity-related complications? (ATTAIN NOW)
- Study IRB#:2000043109
- Last Updated:11/12/2026
If you 18 years of age or older and are living with overweight (BMI: 25-29.9 kg/m2) and a weight-related condition (prediabetes, prehypertension or predyslipidemia) you may qualify for a clinical trial evaluating a daily oral medication which may help with metabolic health.
The ATTAIN-NOW trial is funded by Eli Lilly and the study medication, Orforglipron vs. placebo, is provided at no cost to qualifying participants. The study is 3 years long with regular visits throughout. To qualify, participants cannot have a history of type 2 diabetes or be on medications for weight loss currently.
If you struggle with your weight or metabolic health, and would like to learn more, contact us to see if you qualify and are eligible to participate. Please email yweight@yale.edu and provide the best contact phone number where we can reach you, take the Y-Weight Participate In Research survey at https://medicine.yale.edu/y-weight/contact/
or call us at 203-737-3000.
- Age18 years and older
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Jessica Dean
- Phone Number: 203-737-3000
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877-978-8343 for more information.
Study Location
- Yale University
Eligibility Criteria
Participants with prehypertension and/or predyslipidemia.
participants cannot have a history of type 2 diabetes.